Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

BHARAT PARENTERALS LTD.

NSE : NABSE : 541096ISIN CODE : INE365Y01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE1128.8067.8 (+6.39 %)
PREV CLOSE () 1061.00
OPEN PRICE () 1098.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 630
TODAY'S LOW / HIGH ()1097.95 1129.95
52 WK LOW / HIGH () 8021771.95
NSE
This Company is not listed in NSE
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1992

Management Info :

Bharat Desai - Chairman Bharat Desai - Managing Director

Registered Office :

Address : Survey No. 144 A,Jarod - Samlaya Road,Haripura, Savli,
Vadodara,
Gujarat-391520

Phone : 02667 - 251670, 251680, 9909928332

Website : www.bplindia.in

Registrar's Details : Adroit Corporate Services Pvt Ltd
18-20, 1st floor, Plot No 639,Makwana Road,,Marol, Andheri (East),Mumbai
Listing : BSE
NEWS
09Dec Bharat Parenterals informs about repo
In accordance with SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/..
04Dec Bharat Parenterals informs about newsp
Pursuant to Regulation 30 of SEBI Listing Regulation, Bharat Parenterals..
28Nov FAMHP concludes EU GMP inspection at f
Federal Agency for Medicines and Health Products, Belgium (FAMHP) has co..
27Nov Bharat Parenterals informs about analy
Bharat Parenterals has informed that representatives of the Company will..
04Sep Bharat Parenterals informs about AGM
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosur..
Financials
in Millions
QTR Sep 25 ANNUAL 25
Net Profit27.3264.5
Gross Profit 34.2 363.1
Operating Profit 65.5481.5
Net Sales 4173041.3
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Amrutanjan Healthcar (BSE)
 689.65 (6.38%)
M.Cap ( in Cr)
1993.82
Lupin (BSE)
 2114.10 (1.62%)
M.Cap ( in Cr)
96571.84
Panacea Biotec (BSE)
 362.70 (9.53%)
M.Cap ( in Cr)
2221.56
Emcure Pharma (BSE)
 1439.60 (2.18%)
M.Cap ( in Cr)
27289.76
Aurobindo Pharma (BSE)
 1193.70 (1.81%)
M.Cap ( in Cr)
69330.29
Shareholding Pattern
PROMOTERS 67.19%
NON-INSTITUTION 32.15%
FI/BANKS/INSURANCE 0.01%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%
Mf Holding
Scheme NameHold(%)
No Data Found
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX85267.66449.53 (0.53%)
NIFTY26046.95148.40 (0.57%)
Dow Jones 48458.05-245.96 (-0.51%)
Nasdaq 23195.17-398.69 (-1.69%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI